Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control

Chimeric antigen receptor T cells (CAR-T), especially against CD19 marker, present in lymphomas and acute B leukemia, enabled a revolution in the treatment of hematologic neoplastic diseases. The manufacture of CAR-T cells requires the adoption of GMP-compatible methods and it demands the collection...

Descripción completa

Detalles Bibliográficos
Autores principales: De Santis, Gil Cunha, Langhi Junior, Dante Mário, Feitoza, Andreza, Mendrone Junior, Alfredo, Kutner, José Mauro, Covas, Dimas Tadeu, Couto, Samuel Campanelli Freitas, Guerino-Cunha, Renato L., Orellana, Maristela Delgado, Rizzo, Sílvia Renata Cornelio Parolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606711/
https://www.ncbi.nlm.nih.gov/pubmed/34794795
http://dx.doi.org/10.1016/j.htct.2021.09.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606711/
https://www.ncbi.nlm.nih.gov/pubmed/34794795
http://dx.doi.org/10.1016/j.htct.2021.09.005

Ejemplares similares